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Abstract
Introduction: Recurrent goitre is a significant clinical problem among patients who have been operated due to benign lesions. An atypical
localization of recurrent goitre — near the hyoid bone — poses additional difficulties as there are no data available on the clinical signifi-
cance of such lesions.
The aim of this study was to analyze if this unusual localization of recurrence is related to any significant differences in the clinical course,
and if it significantly increases the risk of thyroid neoplasm.
Material and methods: The outcomes of ultrasound (US) and cytological examinations of 62 patients presenting with a goitre recurrence
localised as a focal lesion near the hyoid bone were analyzed (mean age 59.4 ± 12.4 years). The analysis included the period from the
operation to the lesion-revealing US, the lesion’s volume, the presence of ultrasound features of malignancy, the volume of residual
thyroid tissue in the thyroid bed, the changes in volumes of examined structures, and the outcomes of cytological examinations.
Results: The mean period from the surgery to the US confirming the lesion presence was 16 years, the mean volume of lesion was 2.17 cm3,
and the mean period of observation was 3.2 years (ranging from 1 to 10). Fine needle aspiration biopsy was performed in 47 (76%) focal
lesions. The cytological results were never suspicious or malignant. In 38% of patients in whom control US was done within the observa-
tion period, the lesions enlarged by 20% or more, in 21% of them — by 50%, and in 15% — by over 100%. The category of cytological result
did not imply any significant change, even in the case of significant isolated increase in volume of the lesion near the hyoid bone.
Conclusions: Focal lesions near the hyoid bone, revealed in patients operated previously for benign goitre, are not related to increased risk
of thyroid neoplasm, and their enlargement does not imply their malignancy.
(Pol J Endocrinol 2010; 61 (5): 448–453)
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Streszczenie
Wstęp: Wole nawrotowe u pacjentów po operacji tarczycy z powodu zmian łagodnych stanowi istotny problem kliniczny. Nietypowa
lokalizacja wola w okolicy kości gnykowej stwarza dodatkowe trudności, ze względu na brak danych na temat klinicznego ryzyka takich
zmian. Celem pracy była ocena czy taka nietypowa lokalizacja zmian wiąże się z odmiennym przebiegiem klinicznym oraz istotnym
ryzykiem obecności nowotworu/raka tarczycy.
Materiał i metody: Analizie poddano kolejne wyniki badań ultrasonograficznych (USG) i biopsji aspiracyjnych cienkoigłowych (BAC)
62 pacjentów (śr. wieku 59,4 ± 12,4 lat). Oceniono czas jaki minął od operacji do ujawnienia zmiany w okolicy kości gnykowej, jej objętość,
obecność ultrasonograficznych cech złośliwości w zmianie, objętość miąższu tarczycy w loży płatów, zmiany objętości powyższych struk-
tur i wyniki badań cytologicznych ujawnionych zmian.
Wyniki: Średni czas od operacji do potwierdzenia obecności zmiany w USG wynosił 16 lat, średnia objętość zmiany — 2,17cm3, średni
okres obserwacji — 3,2 lat (1–10 lat). Biopsji aspiracyjnej cienkoigłowej poddano 47 zmian (76%), wynik badania w żadnym przypadku nie
wskazywał na zmianę złośliwą bądź podejrzaną. Co najmniej 20-procentowy wzrost objętości zmiany obserwowano u 38% pacjentów
poddanych kontrolnemu USG, 50-procentowy wzrost u 21% pacjentów, a ponad 100-procentowy — u 15% osób. Kontrolne biopsje nie
przyniosły istotnej zmiany kategorii wyniku biopsji, nawet w przypadku izolowanego znacznego wzrostu objętości ogniska w okolicy
kości gnykowej.
Wnioski: Zmiany ogniskowe okolicy kości gnykowej ujawnione u pacjentów operowanych wcześniej z powodu wola łagodnego nie
wiążą się z wyższym ryzykiem obecności nowotworu/raka tarczycy, powiększanie się takich zmian nie jest dowodem ich złośliwego
charakteru. (Endokrynol Pol 2010; 61 (5): 448–453)
Słowa kluczowe: tarczyca, wole nawrotowe, tyreoidektomia, zmiany łagodne
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Introduction
Recurrent goitre among patients who have been previ-
ously operated due to benign lesions of the thyroid
gland is still an important clinical problem in Poland. It
seems to be the result of several factors, among them
a history of long-term insufficient iodine-prophylaxis
and insufficient post-thyroidectomy treatment and fol-
low-up. The decision regarding reoperation of patients
with recurrent goitre should be based on particularly
strong indications since the risk of complications after
such treatment is significantly higher in comparison
with primary surgery. It is also worth mentioning that
referred patients often belong to the group of elderly
people with co-existing diseases.
Particular diagnostic difficulties are encountered in
patients with non-typically located recurrent goitre, e.g.
at the upper frontal part of the neck near the hyoid bone.
It has not been analyzed yet whether such localization
of recurrent goitre results in a different risk of malig-
nancy or different pattern of changes in lesion volume
or cytological outcome in comparison to those of typi-
cal lateral lobe localization.
The aim of this study was to analyze the outcomes
of ultrasound (US) and fine needle aspiration biopsy
(FNAB) examinations performed in patients with recur-
rent goitre localized at the upper frontal part of the neck
and to investigate if this unusual localization is related
to any significant differences in the clinical course or to
significant risk of malignancy.
Material and methods
The analysis was performed on the US and FNAB out-
comes in a group of 62 patients (women only, aged
32–86 years, mean 59.4 ± 12.4) who had been previous-
ly operated due to benign goitre. The thyroid surgeries
were performed at several clinics in Łódź. In general,
the patients were referred for surgical treatment for rea-
sons other than suspicious FNAB outcome — with the
exception for only 4 patients (6.5%) (follicular neoplasm
in 2 cases, oncocytic cell tumour in 1 case, and the pres-
ence of thyroid follicular cells with intranuclear grooves
in 1 case) — usually because of nodular or toxic goitre,
notwithstanding the benign outcome of FNAB. In the
majority of cases the patients had previously undergone
subtotal thyroidectomy, in 1 case hemithyroidectomy,
and in 5 cases the extent of surgery was not determined
because of the long period since the surgery and miss-
ing medical documentation. In the studied group,
9 patients were operated for the second time because
of goitre recurrence within several years from the first
thyroid surgery. The majority of patients (45–72.6%) had
received levothyroxine treatment with substitutive dos-
es (75–125 mg, the serum TSH levels were normal on
the first and the following examinations), 4 patients
(6.4%) had been treated with Thiamazole because of
recurrent hyperthyroidism, and 13 patients (21.0%) had
not received any pharmacological treatment as they
were euthyroid during the observation period.
In all the patients, a focal lesion near the hyoid bone
(FLNHB) was revealed in the postoperative US, and it
showed no connection to the residual thyroid tissue
located typically. The analysis included: the period from
the operation to the lesion-revealing US, the lesion’s
volume, palpability, echo structure (solid, mixed, cys-
tic), presence of ultrasound features of malignancy (such
as marked hypoechogenicity, microcalcifications, in-
creased internal blood flow, irregular or blurred mar-
gins), and the results of cytological examinations. All of
the same parameters were assessed for the residual thy-
roid tissue in the thyroid bed and for any lesions found
there. The study also included the control examination
outcomes, and special attention was paid to the pattern
of lesion volume change and to possible changes in cy-
tological outcomes in control FNABs. Lesion volume
was measured with the use of simplified elliptical shape
volume formula: 1/2 × width × depth × length of the
measured structure. In order to analyze the significance
of the lesion growth, three threshold points were ap-
plied: 20%, 50%, and 100%.
All the US examinations were performed by a team
of three physicians with at least five years experience,
using the same equipment — an Elegra Advanced (Sie-
mens Medical Systems Inc., Issaquah, WA, USA) with
a 7.5 MHz linear transducer and power Doppler capabil-
ity. All the biopsies were US guided. In order to obtain
a sufficient amount of diagnostic material, usually two
aspirations of each examined lesion were performed.
Ten millilitre syringes mounted in the aspirating syringe
holders with 25 gauge (0.5 or 0.42 mm) needles were
used in the process. In the case of cystic lesions the cy-
tocentrifugation technique was employed for aspirate
preparation, enabling the cell condensation from any
residual material which was left in the syringe. All
smears were fixed in 95% ethanol and stained with hae-
matoxylin and eosin. The guidelines formulated in the
Bethesda system for reporting thyroid cytopathology
were accepted as the criteria for non-diagnostic smears
[1]. The precise methods of classifying FNAB outcomes
into categories were fully described previously [2, 3].
The category ‘benign lesions’ included the outcomes
with ‘benign lesions’ in conclusion or with ‘nodular
goitre’, ‘thyroiditis’, or ‘thyroid cyst’ diagnosed – apart
from haemorrhagic cysts. The category ‘suspected le-
sions’ included the outcomes with ‘follicular neoplasm/
/suspicious for follicular neoplasm’, ‘oxyphilic neoplasm/
/suspicious for a follicular neoplasm, oxyphilic cell type’,
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and with disturbing, hardly diagnosable cytological pic-
ture — ‘unclassified suspected lesions/suspicious for
malignancy’. The category ‘malignant lesions’ includ-
ed the outcomes with malignant tumour diagnosed.
Continuous variables were analysed by t-Student
test. The comparison of frequency distributions was
performed with c2 test. A value of 0.05 was assumed as
the level of significance.
Results
The mean period from the surgical intervention to the
ultrasound examination confirming FLNHB presence
with no connection to the residual thyroid tissue locat-
ed typically was 16 years (ranging from 3 months to
45 years). Those lesions were easily palpable in 22 out
of 62 patients (35%). Their mean volume was 2.17 ±
± 2.12 cm3 (mean ± SD) (Fig. 1). In 3 patients there was
no residual thyroid tissue in the thyroid bed, and in the
remaining group the mean volume of thyroid remnants
was 11.9 ± 10.9 cm3.
The echogenicity of FLNHB was similar to the reg-
ular thyroid tissue in 19 cases (30.6%), and it was slight-
ly diminished in 37 cases (59.7%). In the remaining
group (6 patients, 9.7%) the structure was solid-cystic
and the solid part was non-homogenous. In one case,
the US revealed microcalcifications in the examined le-
sion. Apart from that, none of the remaining FLNHB
presented US features which might have implied a risk
of malignancy (Table I).
Figure 1. Focal lesion in the upper-frontal part of the neck, thyroid follicular cells revealed in FNAB
Rycina 1. Zmiana ogniskowa ujawniona w badaniu USG w górnej części przedniej okolicy szyi, w BAC ujawniono komórki pęcherzykowe
tarczycy
Table I. The categorization of fine-needle aspiration biopsy (FNAB) results of lesions located near the hyoid bone
Tabela I. Kategorie wyników badań cytologicznych zmian położonych w okolicy kości gnykowej
Cytological results of lesions Categories of Number Echo structure
located near the hyoid bone  cytological outcomes and % of FNABs of lesions
Non-suspected cytological picture (thyroid Benign lesions 37 — 78.7 29 — solid, hypoechoic
follicular cells or thyroid follicular cells with 1 — solid, hypoechoic with
mild anisocytosis or admixture of follicular microcalcifications
cells and Hürthle cells in a background 7 — solid, normo-echoic
of abundant colloid and macrophages)
Chronic thyroiditis Lesions of 3 — 6.4 solid, hypoechoic
Postoperative granuloma non-thyroidal origin 3 — 6.4 mixed:solid-cystic
Epidermal cyst 1 — 2.1 mixed:solid-cystic
Specimen lacking cytological material Non-diagnostic 3 — 6.4 2 — mixed:solid-cystic
1 — solid, hypoechoic
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Fine needle biopsy was performed in 47 patients
(75.8%). In all cases the lesions near the hyoid bone were
examined, and additionally in 22 patients recurrent
goitre in typical localization was biopsied. The cytolog-
ical outcome of FLNHB revealed a post-surgical granu-
loma in 3 cases, epidermic cyst in 1 patient, and follicu-
lar thyroid cells in 40 cases. In 3 cases the outcome was
non-diagnostic (Table I). The cytological outcome was
not classified as suspicious or malignant in any of the
cases. Cytological examination of focal lesions found in
the thyroid bed in 1 patient revealed metastasis of non-
microcellular lung cancer. In a biopsy of the FLNHB
observed in this patient neoplastic cells were absent and
only normal thyroid follicular cells, colloid, and mac-
rophages were found. In other cases the outcomes of
the FNAB of the recurrent goitre in the typical lateral
lobe localization indicated the presence of benign thy-
roid lesions.
The control US examinations (1 to 4 control US ex-
aminations) were performed in 34 patients. This group
included only patients with the presence of thyroid fol-
licular cells in FLNHB, confirmed by FNAB. In all the
patients, remnant thyroid tissues were present in the
thyroid bed. The mean period of observation was
3.2 years (ranging from 1 to 10 years). No statistically sig-
nificant differences in mean volume of examined struc-
tures between the first and last examination were found,
neither in FLNHB (2.17 ± 2.12 cm3  v. 2.28 ± 2.21 cm3;
mean ± SD) nor in the structures in the thyroid bed
(11.9 ± 10.9 cm3 v. 13.5 ± 12.41 cm3). In 2 patients (5.9%)
FLNHB volume remained constant between control US
examinations, in 10 patients (29.4%) it decreased, and
in 22 patients (64.7%) it increased. Different limits of
volume change between control examinations were test-
ed and the results are summarized in Table II. The FLN-
HB volume changed at least by 20% in 19 patients
(55.9%); in 13 cases (38.2%) it increased. In 9 patients
FLNHB changed in volume at least by 50%, and in 7 of
them (20.6%) it increased. In 5 cases (14.7%) the lesion
volume increased by more than 100%. The enlargement
of thyroid remnants in the typical localization was found
in a similar percentage of patients — the volume of thy-
roidal residues increased by at least 20% in 13 patients
(38.2%) and by at least 50% in 8 patients (23.5%). In
6 cases the enlargement of the residual tissue exceeded
100%. In 8 out of 13 patients (61.5%) in whom FLNHB
volume increased by at least 20% this change was ac-
companied by an analogous increase in the volume of
the residual thyroid tissue in the thyroid bed. In 2 cases
that enlargement was over 100%. Conversely, in 5 pa-
tients (14.7%) the 20% enlargement of FLNHB was iso-
lated and was not accompanied by the enlargement of
the residual thyroid. At least 50% isolated enlargement
of FLNHB was found in 5 patients and at least 100%
enlargement in 3 cases (Table II).
The control US examinations did not reveal changes
in the echogenicity and echo structure of the examined
lesions, nor did they show any evolution of features sug-
gestive of malignancy. All the examined patients had
normal TSH levels. The majority of them (30 out of 34)
were treated with substitutive doses of levothyroxine. In
none of the 4 patients without substitutive therapy was
significant enlargement of goitre observed.
Control FNABs of FLNHB were performed in
18 patients including all 13 patients in whom its increase
was above 20%. In 4 cases the cytological picture was
slightly changed but the category of cytological outcome
remained the same. In 1 patient (with FLNHB isolated
enlargement above 20% but less than 50%) the cytolog-
ical picture changed from ‘normal follicular thyroid cells’
to ‘follicular cells with mild anisocytosis’. In 2 cases (with
changes in lesion volume below 20%) the cytological
picture changed in the opposite way. In the 1 remain-
ing case (also with volume changes below 20%) the pic-
Table II. The volume changes of lesions located near the hyoid bone and thyroid remnants in its bed
Tabela II. Zmiany objętości struktur zlokalizowanych w okolicy kości gnykowej oraz miąższu resztkowego tarczycy w jej
loży
Cut-off point for volume % of all monitored patients
enlargement
Enlargement of Enlargement Isolated Enlargement of both
lesion located near of thyroidal enlargement lesion located near
the hyoid bone residues in bed of lesion located the hyoid bone and
near the hyoid bone thyroidal residues in bed
> 0% 22/64.7% 19/55.9% 10/29.4% 12/35.3%
> 20% 13/38.2% 13/38.2% 5/14.7% 8/23.5%
> 50% 7/20.6% 8/23.5% 5/14.7% 2/5.9%
> 100% 5/14.7% 6/17.6% 3/8.8% 2/5.9%
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ture of benign non-inflammation lesion changed to
‘chronic thyroiditis’. No patients examined in this study
were referred to the repeated thyroidectomy due to
goitre recurrence in the unusual localization.
Discussion
The reasons why a goitre starts growing in an abnor-
mal localization are still the subject of research. There
are several possible explanations of such a condition. It
could be the result of some abnormalities during the
embryogenesis [4, 5]. As a result of such disorders, the
entire thyroid gland can be ill-positioned, and this can
lead to so-called thyroid gland ectopy. Moreover, there
can be a situation in which the thyroid gland is located
in the right place but with co-existing gland-type tissue
foci in some alternative locations — some authors call
them split-off thyroid foci [4]. In none of the patients of
the examined group were such disorders found in im-
aging examinations before the surgery.
Another, more probable explanation assumes the
growth of previously invisible thyroid tissue in the lo-
calization tracking the embryonal route of thyroid an-
lage. In fact, a pyramidal lobe is present in some 50% of
individuals, and in some of them it is long enough to
reach the hyoid bone [6]. If not resected during prima-
ry surgery, it may be the source of recurrence. It may
grow and may appear as a nodule, especially in condi-
tions of hyperstimulation by TSH due to insufficient
postoperative substitutive treatment [4]. The patients
in the studied group had normal TSH levels during the
observation, but no data was available on the sufficien-
cy of substitutive treatment in the period before the
study. It is reasonable to assume that such treatment
was not optimal in some of the cases. Similarly, the rel-
atively long mean period from the surgical interven-
tion to the US confirming the presence of the lesion in
unusual localization is — in our opinion — the result of
delayed control US examination and does not reflect
the true growth pattern of those lesions.
Some investigators have suggested that in patients
with nodular goitre, some nodules may exist detached
from the main gland although still connected to it by
a vascular pedicle [7]. However, no connection was found
in any of the patients in our study between the nodules
located near the hyoid bone and the thyroid bed.
Other possible explanations are related to the surgi-
cal procedure itself and include the accidental transplant
of some thyroid cells to the observed localization [7–9].
Harach et al. reported eight cases of thyroid implanta-
tion after surgery, of which only one was thyroid can-
cer and the others were related to benign lesions [7].
Koh et al. reported a patient with multiple palpable sub-
cutaneous nodules after endoscopic hemithyroidecto-
my for a benign thyroid nodule by the breast approach
[8]. The recent review by Moon et al. supports theories
that surgery is more frequently the cause of extrathy-
roidal implantation of thyroid cells in the case of be-
nign lesions and that FNAB is a possible cause of the
implantation of cancer cells [9].
Moreover, Harach et al. suggested that a blunt trau-
ma to the neck could be a possible aetiology of benign
thyroid tissue deposits beyond the typical localization
[7]. This shows that traumatic background should also
be taken into consideration in the differential diagno-
sis. However, none of the examined patients in the stud-
ied group had a history positive for a neck trauma.
From a clinical point of view, it is important that —
according to our results — lesions in the upper-frontal
part of the neck in patients previously operated for be-
nign goitre do not cause any significant differences in
the clinical course, nor do they relate to increased risk
of malignancy in comparison with the recurrent goitre
in the thyroid bed. The changes in volume of those le-
sions have a similar pattern to those of thyroid rem-
nants, and their enlargement does not seem to be an
alarming issue if it is not accompanied by ultrasound
features suggestive of increased risk of malignancy. Sim-
ilarly, Alexander et al. found that the majority of solid
benign thyroid nodules tend to grow. Therefore, an in-
crease in nodule volume alone is not a reliable predic-
tor of malignancy [10]. In this study we evaluated three
thresholds of significant change of the focal volume —
at least 20%, 50%, and 100%. The revised ATA Thyroid
Cancer Guidelines recommend a 50% cutoff for nodule
volume growth as the most appropriate and safe for
making decisions on performing control FNAB [11]. It
should be stressed that we did not observe any signifi-
cant change in cytological outcome even in the case of
isolated 50% or 100% enlargement of FLNHB. Thus,
FLNHB enlargement, similarly to the enlargement of
the goitre in the thyroid bed, is not evidence of the
malignant character of the lesion if it is not accompa-
nied by other features suggestive of malignancy.
Conclusions
In conclusion, patients who have been operated on due
to benign goitre require systematic endocrinological
care. The care should include not only substitutive
levothyroxine treatment but also repeated ultrasound
imaging in order to prompt diagnosis of possible recur-
rence of goitre. While performing a US examination one
should take into consideration the possible presence of
thyroid lesions outside the thyroid bed. Such lesions
need cytological verification by fine needle aspiration
biopsy. There is always a possibility of cancer being
omitted during the postoperative histopathological ex-
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amination of the thyroid excised during the primary
intervention or of the malignant lesion growing in the
recurrent goitre. However, lesions located near the hy-
oid bone are usually composed of normal thyroid tis-
sue and are not related to any significant differences in
the clinical course or to increased risk of malignancy in
comparison with the recurrent goitre in the normal lat-
eral lobe bed.
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